Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial

Combined pre-and post-capillary hypertension (CpcPH) is a relatively common complication of heart failure (HF) associated with a poor prognosis. Currently, there is no specific therapy approved for this entity. Recently, treatment with beta-3 adrenergic receptor (β3AR) agonists was able to improve p...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Lunar, Ines, Blanco, Isabel, Fernández-Friera, Leticia, Prat-Gonzàlez, Susanna, Jordà, Paloma, Sánchez, Javier, Pereda, Daniel, Pujadas, Sandra, Rivas, Mercedes, Solé-Gonzalez, Eduard, Vázquez, Jorge, Blázquez, Zorba, García-Picart, Juan, Caravaca, Pedro, Escalera, Noemí, Garcia-Pavia, Pablo, Delgado, Juan, Segovia-Cubero, Javier, Fuster, Valentín, Roig, Eulalia, Barberá, Joan Albert, Ibanez, Borja, García-Álvarez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
CLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188870/
https://www.ncbi.nlm.nih.gov/pubmed/32368692
http://dx.doi.org/10.1016/j.jacbts.2020.01.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188870/
https://www.ncbi.nlm.nih.gov/pubmed/32368692
http://dx.doi.org/10.1016/j.jacbts.2020.01.009

Ejemplares similares